# Suzhou Forlong Biotechnology

Source: https://onco.cc/companies/suzhou-forlong-biotechnology/  
OnCo record `suzhou-forlong-biotechnology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Suzhou Forlong Biotechnology is a China-based biotechnology company running 2 late-stage cancer trials of FL115 in bladder & urothelial cancer.

## Summary

Suzhou Forlong Biotechnology, based in Suzhou, China, is a biotechnology company. Suzhou Forlong Biotechnology (also styled Furong Biotech) develops next-generation cytokine drugs based on synthetic immunology, using platforms for long-acting optimisation, Fc engineering, AI-driven discovery and synthetic cytokine creation. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing FL115 in bladder & urothelial cancer. The largest, NCT07131202 (A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumours), plans to enrol 130 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Suzhou Forlong Biotechnology Co., Ltd
- Tags: ctgov-sponsor
- HQ: Suzhou
- Type: biotech
- Website: https://www.forlongbiotech.com

## Sources

- Official website: https://www.forlongbiotech.com
- ClinicalTrials.gov: trials led by Suzhou Forlong Biotechnology: https://clinicaltrials.gov/search?lead=Suzhou%20Forlong%20Biotechnology%20Co.%2C%20Ltd

## Connected records

- cancers: [Bladder & urothelial cancer](https://onco.cc/cancers/urothelial/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)
- trials: [A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors](https://onco.cc/trials/nct07131202/), [A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer](https://onco.cc/trials/nct07122414/)

---
JSON: https://onco.cc/api/v1/entities/suzhou-forlong-biotechnology.json